درباره این اپیزود
Breakthroughs in the last decade have transformed how we understand and treat multiple sclerosis (MS), but what will it take to stop the disease in its tracks? Pull up a stool with co-host Maria Wilson and our guest Sherman Jia, Group Medical Director, gRED Translational Medicine, for a discussion on the breakthrough research into B cells that has made a "night and day" difference for people living with the disease. In this episode, they tackle the next frontiers in MS research: from the surprising link between the Epstein-Barr virus and MS, to the ambitious goal of repairing the brain’s myelin, and the potential of “immune reset” therapies, including work in cell therapies, that could offer lasting remission.
Read the full text transcript at www.gene.com/stories/breakthroughs-in-ms
Read the full text transcript at www.gene.com/stories/breakthroughs-in-ms
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Two Scientists Walk Into a Bar را جستجو کن.
قسمت های دیگر در این پادکست
Cell therapy holds immense potential to transform the way we treat conditions in oncology, ophthalmology, autoimmune disorders, and a wide range of other therapeutic areas. But how do these engineered cells work, and how do scientists ensure they are safe and function as intended? In this episode, …
From our first breath, the air we breathe and our genes shape how our lungs function. It’s a complex interplay we began exploring in our season four episode “Take A Deep Breath: Treating Asthma.” Today, we’re branching out to discuss lung biology and the diseases that make it difficult to breathe. …
Digital twins are virtual models of real-world systems that have been gaining momentum as a powerful tool in drug discovery and development. We touched on this concept last season when we covered computational advancements in drug discovery. Now, we’re taking a deeper dive into the power of digital…
We published our first episode on the threat of antibiotic resistance in 2016, and nearly a decade later, it remains one of the world’s most pressing health crises. Today, with advances in artificial intelligence (AI), the race to develop new antibiotics is evolving. In this episode, co-host Daniel…
Each season we discuss new, exciting breakthroughs in cancer research. With evolving technologies enhancing how we understand and target the underlying drivers of cancer, the journey to developing more effective and safer therapies is advancing rapidly. In this episode, co-host Danielle Mandikian s…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Genentech است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
